Last 7 days
-35.2%
Last 30 days
-43.0%
Last 90 days
-62.6%
Trailing 12 Months
-61.2%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 9.7M | 15.6M | 21.1M | 0 |
2022 | 1.7M | 1.3M | 1.1M | 3.7M |
2021 | 2.8M | 2.9M | 2.9M | 2.4M |
2020 | 3.1M | 3.1M | 3.3M | 2.9M |
2019 | 2.8M | 3.3M | 3.2M | 2.6M |
2018 | 2.3M | 2.1M | 2.1M | 3.0M |
2017 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 16, 2023 | sarchi christopher | sold | -57,384 | 10.92 | -5,255 | chief commercial officer |
Nov 16, 2023 | xynos konstantinos | sold | -79,858 | 10.92 | -7,313 | chief medical officer |
Sep 18, 2023 | hill emily luisa | acquired | - | - | 83,330 | chief financial officer |
Sep 12, 2023 | esposito pamela | sold | -6,000 | 20.00 | -300 | chief business officer |
Sep 12, 2023 | esposito pamela | acquired | 990 | 3.3 | 300 | chief business officer |
Sep 11, 2023 | esposito pamela | acquired | 17,681 | 3.3 | 5,358 | chief business officer |
Sep 11, 2023 | esposito pamela | sold | -107,214 | 20.01 | -5,358 | chief business officer |
Aug 22, 2023 | esposito pamela | acquired | 122,380 | 6.57957 | 18,600 | chief business officer |
Aug 22, 2023 | esposito pamela | sold | -372,186 | 20.01 | -18,600 | chief business officer |
Aug 11, 2023 | esposito pamela | sold | -28,000 | 20.00 | -1,400 | chief business officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Nov 24, 2023 | DEUTSCHE BANK AG\ | reduced | -86.19 | -2,824,680 | 320,094 | -% |
Nov 22, 2023 | Graham Capital Management, L.P. | new | - | 339,924 | 339,924 | 0.01% |
Nov 21, 2023 | Walleye Capital LLC | sold off | -100 | -1,176,400 | - | -% |
Nov 15, 2023 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | added | 13.88 | -428,589 | 2,235,630 | -% |
Nov 15, 2023 | Tudor Investment Corp Et Al | sold off | -100 | -669,595 | - | -% |
Nov 15, 2023 | MORGAN STANLEY | reduced | -28.18 | -7,145,050 | 8,030,730 | -% |
Nov 15, 2023 | JANE STREET GROUP, LLC | sold off | -100 | -1,870,700 | - | -% |
Nov 15, 2023 | CAPTRUST FINANCIAL ADVISORS | reduced | -3.4 | -296,997 | 733,437 | -% |
Nov 14, 2023 | Voya Investment Management LLC | added | 1.75 | -95,980 | 287,568 | -% |
Nov 14, 2023 | TWO SIGMA INVESTMENTS, LP | sold off | -100 | -4,228,620 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | price t rowe associates inc /md/ | 9.2% | 5,064,744 | SC 13G/A | |
Feb 14, 2023 | redmile group, llc | 9.9% | 5,740,099 | SC 13G/A | |
Feb 14, 2023 | baker bros. advisors lp | 9.99% | 5,768,227 | SC 13G | |
Feb 13, 2023 | omega fund iv, l.p. | 7.2% | 3,610,478 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 5.5% | 3,010,552 | SC 13G | |
Nov 18, 2022 | redmile group, llc | 9.9% | 5,165,131 | SC 13G/A | |
Sep 14, 2022 | atlas venture fund x, l.p. | 4.4% | 2,164,037 | SC 13D/A | |
Feb 14, 2022 | redmile group, llc | 9.9% | 4,775,461 | SC 13G/A | |
Feb 14, 2022 | omega fund iv, l.p. | 10.6% | 5,012,052 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 12.5% | 5,868,638 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Dec 05, 2023 | 8-K | Current Report | |
Nov 17, 2023 | 4 | Insider Trading | |
Nov 17, 2023 | 4 | Insider Trading | |
Nov 07, 2023 | 8-K | Current Report | |
Nov 07, 2023 | 10-Q | Quarterly Report | |
Sep 20, 2023 | 4 | Insider Trading | |
Sep 20, 2023 | 3 | Insider Trading | |
Sep 19, 2023 | 8-K | Current Report | |
Sep 13, 2023 | 4 | Insider Trading | |
Sep 07, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HILS | 31.4B | - | 4.92% | 426363.59% | -3.6K | 218.4K | - | -102.45% |
MRNA | 30.7B | 10.7B | 11.84% | -53.56% | -8.86 | 2.88 | -53.67% | -129.46% |
ALNY | 22.0B | 1.7B | 4.71% | -20.32% | -43.06 | 12.74 | 79.37% | 56.87% |
BMRN | 17.7B | 2.3B | 23.54% | -7.88% | 120.62 | 7.68 | 15.05% | 75.21% |
INCY | 12.4B | 3.6B | 1.56% | -32.86% | 29.22 | 3.44 | 8.35% | -51.49% |
MID-CAP | ||||||||
APLS | 7.5B | 272.9M | 38.55% | 34.32% | -12.3 | 27.31 | 141.38% | 4.43% |
BBIO | 5.6B | - | 16.25% | 246.63% | -9.66 | 48.33 | 54.84% | -12.96% |
ACAD | 3.5B | 631.9M | -10.80% | 43.56% | -23.57 | 5.55 | 23.54% | 31.53% |
AXSM | 3.3B | 223.4M | 11.07% | -7.88% | -16.25 | 14.68 | - | -26.24% |
ARWR | 2.6B | 240.7M | -11.66% | -25.68% | -12.44 | 10.6 | -1.03% | -16.59% |
SMALL-CAP | ||||||||
CPRX | 1.5B | 348.4M | 7.85% | -14.88% | 24.07 | 4.29 | 81.69% | -7.29% |
NVAX | 662.5M | 1.0B | -19.01% | -66.75% | -1.21 | 0.63 | -43.15% | 58.48% |
INO | 100.5M | 6.4M | -2.56% | -78.77% | -0.61 | 15.6 | -44.11% | 50.48% |
IBIO | 42.3M | - | 410.00% | -4.38% | -0.65 | - | - | -29.23% |
CRBP | 26.3M | - | 17.86% | 4717.52% | -0.55 | - | - | -13.74% |
Income Statement (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | -2.2% | 6,049,000 | 6,186,000 | 6,145,000 | 2,675,000 | 574,000 | 343,000 | 131,000 | 87,000 | 725,000 | 788,000 | 816,000 | 550,000 | 755,000 | 686,000 | 859,000 | 951,000 | 620,000 | 687,000 | 325,500 | 1,577,000 | 664,000 |
Operating Expenses | 14.7% | 63,831,000 | 55,648,000 | 52,995,000 | 41,630,000 | 41,579,000 | 40,876,000 | 31,988,000 | 29,698,000 | 29,247,000 | 27,381,000 | 22,184,000 | 20,275,000 | 19,663,000 | 17,833,000 | 16,385,000 | 16,664,000 | 12,242,000 | 10,907,000 | 7,826,000 | 10,137,000 | 7,104,000 |
S&GA Expenses | -3.2% | 14,730,000 | 15,211,000 | 15,041,000 | 11,369,000 | 12,745,000 | 11,398,000 | 10,252,000 | 10,345,000 | 9,345,000 | 8,827,000 | 5,959,000 | 5,953,000 | 5,613,000 | 5,676,000 | 5,197,000 | 4,716,000 | 4,074,000 | 3,450,000 | 2,410,500 | 2,280,000 | 2,142,000 |
R&D Expenses | 21.4% | 49,101,000 | 40,437,000 | 37,954,000 | 30,261,000 | 28,834,000 | 29,478,000 | 21,736,000 | 19,353,000 | 19,902,000 | 18,554,000 | 16,225,000 | 14,322,000 | 14,050,000 | 12,157,000 | 11,188,000 | 11,948,000 | 8,168,000 | 7,457,000 | 5,415,500 | 7,857,000 | 4,962,000 |
EBITDA Margin | - | - | - | -16.95 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | -14.3% | 955,000 | 1,115,000 | 1,022,000 | 941,000 | - | - | - | - | - | - | 1,000 | 247,000 | 286,000 | 284,000 | - | 834,000 | 195,000 | - | - | - | - |
Income Taxes | -200.0% | -200,000 | 200,000 | - | - | - | - | -55,000 | 12,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -22.1% | -60,245,000 | -49,354,000 | - | - | -43,102,000 | -42,253,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBT Margin | - | - | - | -17.39 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -21.1% | -60,044,000 | -49,600,000 | -49,238,000 | -39,690,000 | -43,102,000 | -42,300,000 | -31,696,000 | -29,674,000 | -29,355,000 | -27,311,000 | -21,499,000 | -21,783,000 | -20,095,000 | -17,493,000 | -15,789,000 | -16,189,000 | -11,139,000 | -9,508,000 | -6,656,000 | -7,673,000 | -6,461,000 |
Net Income Margin | - | - | - | -17.42 | -37.05 | -25.61 | -41.13 | -37.22 | -35.22 | -34.72 | -31.17 | -28.81 | -27.59 | -22.26 | -20.64 | -17.06 | -15.24 | - | - | - | - | - |
Free Cashflow | - | - | - | -33,047,000 | -29,144,000 | -33,606,000 | -34,523,000 | -23,709,000 | -18,813,000 | -23,389,000 | -18,605,000 | -16,898,000 | -13,607,000 | -17,254,000 | -16,022,000 | -12,600,000 | -19,791,000 | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | -6.9% | 562 | 604 | 647 | 679 | 436 | 459 | 461 | 485 | 503 | 524 | 543 | 559 | 314 | 330 | 234 | 250 | 151 | 144 | 154 | 152 | 154 |
Current Assets | -7.6% | 508 | 550 | 593 | 624 | 379 | 402 | 404 | 428 | 444 | 465 | 484 | 499 | 252 | 268 | 174 | 191 | 118 | 128 | 141 | 145 | 152 |
Cash Equivalents | -27.1% | 78.00 | 106 | 147 | 207 | 89.00 | 114 | 108 | 134 | 162 | 194 | 184 | 326 | 45.00 | 106 | 61.00 | 63.00 | 65.00 | 40.00 | 27.00 | 22.00 | 24.00 |
Net PPE | 10.9% | 8.00 | 8.00 | 7.00 | 8.00 | 8.00 | 8.00 | 8.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 6.00 | 4.00 | 1.00 | 12.00 | 6.00 | 0.00 |
Liabilities | 8.2% | 97.00 | 90.00 | 91.00 | 83.00 | 52.00 | 49.00 | 50.00 | 48.00 | 46.00 | 45.00 | 44.00 | 43.00 | 53.00 | 52.00 | 50.00 | 53.00 | 31.00 | 13.00 | 16.00 | 9.00 | 4.00 |
Current Liabilities | 23.5% | 40.00 | 32.00 | 34.00 | 26.00 | 24.00 | 20.00 | 21.00 | 18.00 | 17.00 | 15.00 | 15.00 | 13.00 | 13.00 | 12.00 | 12.00 | 14.00 | 12.00 | 13.00 | 10.00 | 4.00 | 4.00 |
Long Term Debt | 0.9% | 29.00 | 29.00 | 29.00 | 28.00 | - | - | - | - | - | - | - | - | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | - | - | - | - |
LT Debt, Non Current | - | - | - | 29.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -9.5% | 465 | 514 | 555 | 595 | 384 | 410 | 411 | 438 | 457 | 479 | 499 | 516 | 261 | 278 | 184 | 198 | 121 | 130 | 138 | 143 | 150 |
Retained Earnings | -11.2% | -595 | -535 | -485 | -436 | -396 | -353 | -311 | -279 | -249 | -220 | -193 | -171 | -149 | -129 | -112 | -96.51 | -80.32 | -69.18 | -59.77 | -53.11 | -45.44 |
Additional Paid-In Capital | 0.9% | 1,055 | 1,045 | 1,035 | 1,028 | 778 | 763 | 723 | 717 | 707 | 700 | 692 | 688 | 412 | 409 | 297 | 295 | 202 | 200 | 199 | 198 | 197 |
Shares Outstanding | 0.1% | 59.00 | 59.00 | 57.00 | 57.00 | 50.00 | 54.00 | 47.00 | 52.00 | 52.00 | 52.00 | 47.00 | 49.00 | 44.00 | 40.00 | 37.00 | 33.00 | 32.00 | 32.00 | 32.00 | 32.00 | 25.00 |
Cashflow (Quarterly) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 10.3% | -43,590 | -48,588 | -32,796 | -28,589 | -33,210 | -33,455 | -22,557 | -18,348 | -22,961 | -18,314 | -16,128 | -12,992 | -17,179 | -15,090 | -11,262 | -15,735 | -19,973 | -13,582 | -6,033 | -6,103 | -6,383 |
Share Based Compensation | 3.0% | 9,115 | 8,846 | 6,922 | 7,023 | 6,992 | 7,194 | 5,773 | 5,918 | 6,313 | 6,250 | 3,472 | 3,049 | 2,801 | 2,468 | 1,806 | 2,344 | 1,781 | 1,810 | 907 | 880 | 718 |
Cashflow From Investing | 72.3% | 12,683 | 7,361 | -22,752 | -125,101 | 36.00 | 5,315 | -4,326 | -13,420 | -11,052 | 26,992 | -126,273 | 31,421 | -44,798 | -49,126 | 7,841 | -65,209 | 25,324 | 26,811 | 10,474 | 3,801 | -85,109 |
Cashflow From Financing | -60.4% | 438 | 1,105 | -77.00 | 271,435 | 7,423 | 32,522 | 359 | 3,969 | 1,150 | 1,120 | 785 | 262,198 | -35.00 | 109,514 | 34.00 | 90,364 | 9,750 | 18.00 | 41.00 | 153 | 101,391 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Operating expenses: | ||||
Research and development | $ 49,101 | $ 28,834 | $ 89,538 | $ 58,312 |
Selling, general and administrative | 14,730 | 12,745 | 29,941 | 24,143 |
Total operating expenses | 63,831 | 41,579 | 119,479 | 82,455 |
Loss from operations | (63,831) | (41,579) | (119,479) | (82,455) |
Other income (expense): | ||||
Research and development incentives | 443 | 574 | 836 | 1,425 |
Investment income | 6,049 | 1,112 | 12,235 | 1,455 |
Interest expense on finance lease liability | (542) | (550) | (1,086) | (1,102) |
Interest expense on debt obligations | (955) | 0 | (2,070) | 0 |
Other (expense) income | (1,409) | (2,659) | (35) | (4,678) |
Total other income (expense), net | 3,586 | (1,523) | 9,880 | (2,900) |
Loss before income taxes | (60,245) | (43,102) | (109,599) | (85,355) |
Income tax (benefit) | (201) | 0 | 0 | 0 |
Net loss | $ (60,044) | $ (43,102) | $ (109,599) | $ (85,355) |
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.90) | $ (0.79) | $ (1.65) | $ (1.57) |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (0.90) | $ (0.79) | $ (1.65) | $ (1.57) |
Weighted average common shares outstanding, basic (in shares) | 66,582,280 | 54,770,291 | 66,475,577 | 54,492,395 |
Weighted average common shares outstanding, diluted (in shares) | 66,582,280 | 54,770,291 | 66,475,577 | 54,492,395 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 75,996 | $ 146,590 |
Short-term investments | 420,765 | 436,796 |
Research and development incentives receivable | 2,900 | 2,939 |
Prepaid expenses and other current assets | 8,514 | 6,278 |
Total current assets | 508,175 | 592,603 |
Property, plant and equipment, net | 8,445 | 7,479 |
Research and development incentives receivable, non-current | 809 | 0 |
Restricted cash | 1,636 | 1,636 |
Right-to-use asset - operating leases | 4,882 | 5,208 |
Right-to-use asset - financing leases | 38,451 | 39,665 |
Total assets | 562,398 | 646,591 |
Current liabilities: | ||
Accounts payable | 4,365 | 5,364 |
Accrued expenses and other current liabilities | 31,651 | 24,704 |
Operating lease liabilities, current | 1,138 | 1,118 |
Financing lease liabilities, current | 2,678 | 2,639 |
Total current liabilities | 39,832 | 33,825 |
Operating lease liabilities, non-current | 4,052 | 4,389 |
Financing lease liabilities, non-current | 23,709 | 23,965 |
Long term debt, net of discount | 29,161 | 28,648 |
Other liabilities, non-current | 472 | 472 |
Total liabilities | 97,226 | 91,299 |
Commitments and contingencies (Note 14) | ||
Stockholders' equity | ||
Common stock, $0.001 par value; 150,000,000 shares authorized as of September 30, 2023 and March 31, 2023; 59,059,343 and 56,676,313 shares issued and outstanding as of September 30, 2023 and March 31, 2023, respectively | 59 | 57 |
Additional paid-in capital | 1,054,712 | 1,034,994 |
Accumulated deficit | (595,087) | (485,488) |
Accumulated other comprehensive income | 5,488 | 5,729 |
Total stockholders' equity | 465,172 | 555,292 |
Total liabilities and stockholders' equity | $ 562,398 | $ 646,591 |
CEO | Mr. Philip Astley-Sparke F.S.A., FSA |
---|---|
WEBSITE | www.replimune.com |
EMPLOYEES | 284 |